Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics
Authors
Keywords
-
Journal
Pharmaceutics
Volume 14, Issue 5, Pages 954
Publisher
MDPI AG
Online
2022-04-29
DOI
10.3390/pharmaceutics14050954
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gold (III) Derivatives in Colon Cancer Treatment
- (2022) Agata Gurba et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- DNA Damage Tolerance Pathways in Human Cells: A Potential Therapeutic Target
- (2022) Ashlynn Ai Li Ler et al. Frontiers in Oncology
- p53 Signaling on Microenvironment and Its Contribution to Tissue Chemoresistance
- (2022) Leonel Cardozo de Menezes e Souza et al. Membranes
- Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance
- (2021) Jing-Quan Wang et al. DRUG RESISTANCE UPDATES
- Multi-Targeted Anticancer Activity of Imidazolate Phosphane Gold(I) Compounds by Inhibition of DHFR and TrxR in Breast Cancer Cells
- (2021) Rossana Galassi et al. Frontiers in Chemistry
- In Vitro and In Vivo Effect of Palladacycles: Targeting A2780 Ovarian Carcinoma Cells and Modulation of Angiogenesis
- (2021) Francisco Reigosa-Chamorro et al. INORGANIC CHEMISTRY
- DNA Repair Pathways in Cancer Therapy and Resistance
- (2021) Lan-ya Li et al. Frontiers in Pharmacology
- Novel Insights into Mice Multi-Organ Metabolism upon Exposure to a Potential Anticancer Pd(II)-Agent
- (2021) Tatiana J. Carneiro et al. Metabolites
- Supramolecular metal-based nanoparticles for drug delivery and cancer therapy
- (2021) Xiaomin Jiang et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Recent advances in biological activities of rhodium complexes: Their applications in drug discovery research
- (2021) Marzieh Sohrabi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pt(IV) Prodrugs with NSAIDs as Axial Ligands
- (2021) Daniil Spector et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?
- (2021) Dan Gibson JOURNAL OF INORGANIC BIOCHEMISTRY
- A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis via the PARP/ATM pathway
- (2021) Yu Lu et al. JOURNAL OF NANOBIOTECHNOLOGY
- Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives
- (2021) Shirin Hafezi et al. Cancers
- Strategies for the Improvement of Metal-Based Chemotherapeutic Treatments
- (2021) Damiano Cirri et al. Biomedicines
- Advancements in the Use of Platinum Complexes as Anticancer Agents
- (2021) Rajiv Sharma et al. Anti-Cancer Agents in Medicinal Chemistry
- The palladacycle, BTC2, exhibits anti-breast cancer and breast cancer stem cell activity
- (2021) Serah Kimani et al. BIOCHEMICAL PHARMACOLOGY
- Platinum and Palladium Complexes as Promising Sources for Antitumor Treatments
- (2021) Robert Czarnomysy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
- (2021) Robert Csaba Kiss et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structure–Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands
- (2021) Philipp Fronik et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ruthenium Complexes as Promising Candidates against Lung Cancer
- (2021) Qi Sun et al. MOLECULES
- The interplay between apoptosis and cellular senescence: Bcl-2 family proteins as targets for cancer therapy
- (2021) Alakananda Basu PHARMACOLOGY & THERAPEUTICS
- Gold Compounds and the Anticancer Immune Response
- (2021) Ling Zhou et al. Frontiers in Pharmacology
- Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
- (2021) Christiana M. Neophytou et al. Cancers
- Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal Cancer Treatment
- (2021) Kazi Mustafa Mahmud et al. Pharmaceutics
- Targeting the BCL-2-regulated apoptotic pathway for the treatment of solid cancers
- (2021) W. Douglas Fairlie et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Platinum-based Anticancer Drugs: Unveiling Novel Mechanisms of Action of Conventional Metallodrugs for Improved Therapies
- (2021) Tiziano Marzo et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Ru(iii) complexes with pyrazolopyrimidines as anticancer agents: bioactivities and the underlying mechanisms
- (2021) Yun-Qiong Gu et al. DALTON TRANSACTIONS
- Impact of the Pd2Spm (Spermine) Complex on the Metabolism of Triple-Negative Breast Cancer Tumors of a Xenograft Mouse Model
- (2021) Tatiana J. Carneiro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Safety and Efficacy Evaluation In Vivo of a Cationic Nucleolipid Nanosystem for the Nanodelivery of a Ruthenium(III) Complex with Superior Anticancer Bioactivity
- (2021) Marialuisa Piccolo et al. Cancers
- Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl2 Complexes
- (2020) Dianna Truong et al. INORGANIC CHEMISTRY
- Rationally Designed Ruthenium Complexes for Breast Cancer Therapy
- (2020) Golara Golbaghi et al. MOLECULES
- Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties
- (2020) Yi Li et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Biological evaluation of novel thiomaltol-based organometallic complexes as topoisomerase IIα inhibitors
- (2020) Maria S. Legina et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
- (2020) Jiabei Zhou et al. Frontiers in Pharmacology
- Gold(III) Complexes: An Overview on Their Kinetics, Interactions With DNA/BSA, Cytotoxic Activity, and Computational Calculations
- (2020) Snežana Radisavljević et al. Frontiers in Chemistry
- Exploring anticancer efficiency of mitochondria-targeted cyclometalated iridium(III) complexes
- (2020) Yiying Gu et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties
- (2020) Ida Landini et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Recent Advances of Gold Compounds in Anticancer Immunity
- (2020) Shuang Yue et al. Frontiers in Chemistry
- Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems
- (2020) Maria Grazia Ferraro et al. Cells
- Synergistic co-loading of vincristine improved chemotherapeutic potential of Pegylated liposomal doxorubicin against triple negative breast cancer and non-small cell lung cancer
- (2020) Saikat Ghosh et al. Nanomedicine-Nanotechnology Biology and Medicine
- Synthesis and structure of a new thiazoline-based palladium(II) complex that promotes cytotoxicity and apoptosis of human promyelocytic leukemia HL-60 cells
- (2020) Javier Espino et al. Scientific Reports
- Metabolic Aspects of Palladium(II) Potential Anti-Cancer Drugs
- (2020) Tatiana J. Carneiro et al. Frontiers in Oncology
- The Effects on Angiogenesis of Relevant Inorganic Chemotherapeutics
- (2020) Tiziano Marzo et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives
- (2020) Sang Yeul Lee et al. Drug Design Development and Therapy
- Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
- (2019) Reece G. Kenny et al. CHEMICAL REVIEWS
- Metal-based antitumor compounds: beyond cisplatin
- (2019) Peter V Simpson et al. Future Medicinal Chemistry
- Differential damage and repair of DNA-adducts induced by anti-cancer drug cisplatin across mouse organs
- (2019) Askar Yimit et al. Nature Communications
- Anticancer activity of palladium-based complexes against triple-negative breast cancer
- (2019) Martin Vojtek et al. DRUG DISCOVERY TODAY
- Potential Anticancer Activity of Auranofin
- (2019) Takefumi Onodera et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Cellular responses of BRCA1-defective HCC1937 breast cancer cells induced by the antimetastasis ruthenium(II) arene compound RAPTA-T
- (2019) Tidarat Nhukeaw et al. APOPTOSIS
- NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
- (2019) Enzo Alessio et al. MOLECULES
- Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug
- (2019) Xiaonan Zhang et al. BIOCHIMIE
- Cisplatin: The first metal based anticancer drug
- (2019) Sumit Ghosh BIOORGANIC CHEMISTRY
- Palladium (0) olefin complexes bearing purine-based N-heterocyclic carbenes and 1,3,5-triaza-7-phosphaadamantane (PTA): Synthesis, characterization and antiproliferative activity toward human ovarian cancer cell lines
- (2019) Thomas Scattolin et al. JOURNAL OF ORGANOMETALLIC CHEMISTRY
- Iridium(III) Complexes Targeting Apoptotic Cell Death in Cancer Cells
- (2019) Dik-Lung Ma et al. MOLECULES
- Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer
- (2019) Marialuisa Piccolo et al. Scientific Reports
- Advances in Toxicological Research of the Anticancer Drug Cisplatin
- (2019) Luyu Qi et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy
- (2019) Xiaoming Zhang et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Chemistry and reactivity of ruthenium(II) complexes: DNA/protein binding mode and anticancer activity are related to the complex structure
- (2019) Ana Rilak Simović et al. COORDINATION CHEMISTRY REVIEWS
- Autophagy-regulating N-heterocycles derivatives as potential anticancer agents
- (2019) Xiaoxia Liang et al. Future Medicinal Chemistry
- Identification of a rhodium(iii) complex as a Wee1 inhibitor against TP53-mutated triple-negative breast cancer cells
- (2018) Guan-Jun Yang et al. CHEMICAL COMMUNICATIONS
- Gold(III) Complexes for Antitumor Applications: An Overview
- (2018) Benoît Bertrand et al. CHEMISTRY-A EUROPEAN JOURNAL
- Mitochondria-targeting Anticancer Metal Complexes
- (2018) Andrea Erxleben CURRENT MEDICINAL CHEMISTRY
- Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents
- (2018) Mousumi Pal et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Anticancer metallodrugs: where is the next cisplatin?
- (2018) Muhammad Hanif et al. Future Medicinal Chemistry
- Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features
- (2018) JuanJuan Li et al. INORGANIC CHEMISTRY
- Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?
- (2018) Sreekanth Thota et al. JOURNAL OF MEDICINAL CHEMISTRY
- Gold-Based Medicine: A Paradigm Shift in Anti-Cancer Therapy?
- (2018) Chien Yeo et al. MOLECULES
- High in vitro anticancer activity of a dinuclear palladium(II) complex with a 2‑phenylpyridine ligand
- (2018) Qi-Pin Qin et al. INORGANIC CHEMISTRY COMMUNICATIONS
- Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433
- (2018) Susan Monro et al. CHEMICAL REVIEWS
- DNA repair pathways and cisplatin resistance: an intimate relationship
- (2018) CR Rocha et al. Clinics
- Applications of Ruthenium Complex in Tumor Diagnosis and Therapy
- (2018) Ke Lin et al. Frontiers in Pharmacology
- Multi-action Pt(IV) anticancer agents; do we understand how they work?
- (2018) Dan Gibson JOURNAL OF INORGANIC BIOCHEMISTRY
- Research progress in modern structure of platinum complexes
- (2017) Linkui Bai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives
- (2017) Tatjana Lazarević et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors
- (2017) Prakash Thangavel et al. International Journal of Nanomedicine
- Recent development of transition metal complexes with in vivo antitumor activity
- (2017) Jia-Xin Liang et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
- (2017) Peter M Bruno et al. NATURE MEDICINE
- Metal complexes in cancer therapy – an update from drug design perspective
- (2017) Umar Ndagi et al. Drug Design Development and Therapy
- A systematic assessment of chemical, genetic, and epigenetic factors influencing the activity of anticancer drug KP1019 (FFC14A)
- (2017) Upendarrao Golla et al. Oncotarget
- The molecular mechanisms of chemoresistance in cancers
- (2017) Hua-Chuan Zheng Oncotarget
- Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action
- (2017) Carlo Irace et al. Scientific Reports
- Electronic State of Sodium trans-[Tetrachloridobis(1H-indazole)ruthenate(III)] (NKP-1339) in Tumor, Liver and Kidney Tissue of a SW480-bearing Mouse
- (2017) Amir Blazevic et al. Scientific Reports
- Metal Containing Cytostatics and Their Interaction with Cellular Thiol Compounds Causing Chemoresistance
- (2016) Jan Hrabeta et al. Anti-Cancer Agents in Medicinal Chemistry
- Platinum-based drugs: past, present and future
- (2016) Shahana Dilruba et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- Thiomaltol-Based Organometallic Complexes with 1-Methylimidazole as Leaving Group: Synthesis, Stability, and Biological Behavior
- (2016) Carmen M. Hackl et al. CHEMISTRY-A EUROPEAN JOURNAL
- Iridium(I) Compounds as Prospective Anticancer Agents: Solution Chemistry, Antiproliferative Profiles and Protein Interactions for a Series of Iridium(I) N-Heterocyclic Carbene Complexes
- (2016) Yvonne Gothe et al. CHEMISTRY-A EUROPEAN JOURNAL
- Mutant p53 Gain of Function and Chemoresistance: The Role of Mutant p53 in Response to Clinical Chemotherapy
- (2016) Chao He et al. CHEMOTHERAPY
- Comprehensive review on tumour active palladium compounds and structure–activity relationships
- (2016) Md Nur Alam et al. COORDINATION CHEMISTRY REVIEWS
- The development of RAPTA compounds for the treatment of tumors
- (2016) Benjamin S. Murray et al. COORDINATION CHEMISTRY REVIEWS
- Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies
- (2016) Gwo Yaw Ho et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Metal-based drugs that break the rules
- (2016) Claire S. Allardyce et al. DALTON TRANSACTIONS
- Coumarin-appended phosphorescent cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents
- (2016) Rui-Rong Ye et al. DALTON TRANSACTIONS
- Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective
- (2016) Enzo Alessio EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- Molecular mode of action of NKP-1339 – a clinically investigated ruthenium-based drug – involves ER- and ROS-related effects in colon carcinoma cell lines
- (2016) Lea S. Flocke et al. INVESTIGATIONAL NEW DRUGS
- Biodistribution of the novel anticancer drug sodium trans -[tetrachloridobis(1 H -indazole)ruthenate(III)] KP-1339/IT139 in nude BALB/c mice and implications on its mode of action
- (2016) Anna K. Bytzek et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- X-ray Structure Analysis of Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism
- (2016) Aleksandar Bijelic et al. JOURNAL OF MEDICINAL CHEMISTRY
- Treatment Effects of WST11 Vascular Targeted Photodynamic Therapy for Urothelial Cell Carcinoma in Swine
- (2016) Katie S. Murray et al. JOURNAL OF UROLOGY
- Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy
- (2016) Mohammad Abid et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- A ruthenium anticancer compound interacts with histones and impacts differently on epigenetic and death pathways compared to cisplatin
- (2016) Cynthia Licona et al. Oncotarget
- Multidrug Resistance Proteins (MRPs) and Cancer Therapy
- (2015) Yun-Kai Zhang et al. AAPS Journal
- Anticancer Gold(III) Porphyrins Target Mitochondrial Chaperone Hsp60
- (2015) Di Hu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The palladacycle, AJ-5, exhibits anti-tumour and anti-cancer stem cell activity in breast cancer cells
- (2015) Saeb Aliwaini et al. CANCER LETTERS
- Cytotoxic activity and protein binding through an unusual oxidative mechanism by an iridium(i)–NHC complex
- (2015) Y. Gothe et al. CHEMICAL COMMUNICATIONS
- Chemical biology of anticancer gold(iii) and gold(i) complexes
- (2015) Taotao Zou et al. CHEMICAL SOCIETY REVIEWS
- Exploring the potential of gold(iii) cyclometallated compounds as cytotoxic agents: variations on the C^N theme
- (2015) B. Bertrand et al. DALTON TRANSACTIONS
- The state-of-play and future of platin drugs
- (2015) M. Apps et al. ENDOCRINE-RELATED CANCER
- Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery
- (2015) Franco M. Muggia et al. JOURNAL OF CLINICAL ONCOLOGY
- Oxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer
- (2015) Jing Yu et al. MEDICINE
- Editorial of Special Issue Ruthenium Complex: The Expanding Chemistry of the Ruthenium Complexes
- (2015) Ileana Dragutan et al. MOLECULES
- Vascular-targeted photodynamic therapy with TOOKAD® Soluble in localized prostate cancer: standardization of the procedure
- (2015) Abdel-Rahmene Azzouzi et al. WORLD JOURNAL OF UROLOGY
- TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer
- (2015) A. R. Azzouzi et al. WORLD JOURNAL OF UROLOGY
- Cationic liposomes as efficient nanocarriers for the drug delivery of an anticancer cholesterol-based ruthenium complex
- (2015) Giuseppe Vitiello et al. Journal of Materials Chemistry B
- Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth
- (2015) Ningning Liu et al. Oncotarget
- Organoiridium Complexes: Anticancer Agents and Catalysts
- (2014) Zhe Liu et al. ACCOUNTS OF CHEMICAL RESEARCH
- Apoptosis-inducing effect of a palladium(II) saccharinate complex of terpyridine on human breast cancer cells in vitro and in vivo
- (2014) Ferda Ari et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes
- (2014) Anant R. Kapdi et al. CHEMICAL SOCIETY REVIEWS
- Palladium Complexes with 3-Substituted Derivatives of 5-Methyl-5-(4-pyridyl)hydantoins. Synthesis, Study and in vitro Cytotoxicity
- (2014) Adriana Bakalova et al. CROATICA CHEMICA ACTA
- NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels
- (2014) Serena Pillozzi et al. DALTON TRANSACTIONS
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
- (2014) Suzanne Leijen et al. INVESTIGATIONAL NEW DRUGS
- NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
- (2014) Robert Trondl et al. Chemical Science
- Antagonism of mTOR Activity by a Kinetically Inert Rhodium(III) Complex
- (2014) Hai-Jing Zhong et al. ChemPlusChem
- Nanocarriers for delivery of platinum anticancer drugs
- (2013) Hardeep S. Oberoi et al. ADVANCED DRUG DELIVERY REVIEWS
- Platinum Compounds: A Hope for Future Cancer Chemotherapy
- (2013) Imran Ali et al. Anti-Cancer Agents in Medicinal Chemistry
- Phase I dose escalation study of the PKCι inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer
- (2013) Aaron S. Mansfield et al. ANTI-CANCER DRUGS
- Platinum compounds in children with cancer
- (2013) Antonio Ruggiero et al. ANTI-CANCER DRUGS
- A novel binuclear palladacycle complex inhibits melanoma growth in vitro and in vivo through apoptosis and autophagy
- (2013) Saeb Aliwaini et al. BIOCHEMICAL PHARMACOLOGY
- Anticancer Cationic Ruthenium Nanovectors: From Rational Molecular Design to Cellular Uptake and Bioactivity
- (2013) Gaetano Mangiapia et al. BIOMACROMOLECULES
- Interaction of Anticancer Ruthenium Compounds with Proteins: High-Resolution X-ray Structures and Raman Microscopy Studies of the Adduct between Hen Egg White Lysozyme and AziRu
- (2013) Alessandro Vergara et al. INORGANIC CHEMISTRY
- Transferrin Serves As a Mediator to Deliver Organometallic Ruthenium(II) Anticancer Complexes into Cells
- (2013) Wei Guo et al. INORGANIC CHEMISTRY
- Multi-targeted organometallic ruthenium(II)–arene anticancer complexes bearing inhibitors of poly(ADP-ribose) polymerase-1: A strategy to improve cytotoxicity
- (2013) Zhigang Wang et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Metallomics for drug development: a further insight into intracellular activation chemistry of a ruthenium(iii)-based anticancer drug gained using a multidimensional analytical approach
- (2013) Magdalena Matczuk et al. Metallomics
- Monitoring Survivin Expression in Cancer: Implications for Prognosis and Therapy
- (2013) Rodrigo Santa Cruz Guindalini et al. Molecular Diagnosis & Therapy
- Current Development of Pd(II) Complexes as Potential Antitumor Agents
- (2012) Enjun Gao et al. Anti-Cancer Agents in Medicinal Chemistry
- Status of Bi- and Multi-Nuclear Platinum Anticancer Drug Development
- (2012) Jinchao Zhang et al. Anti-Cancer Agents in Medicinal Chemistry
- Phosphine-Gold(I) Compounds as Anticancer Agents: General Description and Mechanisms of Action
- (2012) Joao Carlos Lima et al. Anti-Cancer Agents in Medicinal Chemistry
- Cholesterol-Based Nucleolipid-Ruthenium Complex Stabilized by Lipid Aggregates for Antineoplastic Therapy
- (2012) Luca Simeone et al. BIOCONJUGATE CHEMISTRY
- Ruthenium-based complex nanocarriers for cancer therapy
- (2012) Gaetano Mangiapia et al. BIOMATERIALS
- Next-Generation Anticancer Metallodrugs
- (2012) Seiji Komeda et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Rhodium(III) and iridium(III) complexes as anticancer agents
- (2012) Yvonne Geldmacher et al. INORGANICA CHIMICA ACTA
- Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data
- (2012) Antonio Rossi et al. JOURNAL OF CLINICAL ONCOLOGY
- Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells
- (2012) Jade B. Aitken et al. Metallomics
- NOXA-Induced Alterations in the Bax/Smac Axis Enhance Sensitivity of Ovarian Cancer Cells to Cisplatin
- (2012) Chao Lin et al. PLoS One
- NKP-1339, a first-in-class anticancer drug showing mild side effects and activity in patients suffering from advanced refractory cancer
- (2012) Robert Trondl et al. BMC Pharmacology & Toxicology
- Anticancer Metallotherapeutics in Preclinical Development
- (2011) G. N. Kaluderovic et al. CURRENT MEDICINAL CHEMISTRY
- Transition Metal Based Anticancer Drugs
- (2011) K. Benjamin Garbutcheon-Singh et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
- (2011) Alberta Bergamo et al. DALTON TRANSACTIONS
- Mammalian multidrug-resistance proteins (MRPs)
- (2011) Andrew J. Slot et al. Essays in Biochemistry
- Anti-cancer activity of a novel palladium(II) complex on human breast cancer cells in vitro and in vivo
- (2011) Engin Ulukaya et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pyridine Analogues of the Antimetastatic Ru(III) Complex NAMI-A Targeting Non-Covalent Interactions with Albumin
- (2011) Michael I. Webb et al. INORGANIC CHEMISTRY
- Approaching tumour therapy beyond platinum drugs
- (2011) A. Bergamo et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Overcoming cisplatin resistance using gold(III) mimics: Anticancer activity of novel gold(III) polypyridyl complexes
- (2011) Kamalakannan Palanichamy et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Organometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity
- (2011) Patrycja Nowak-Sliwinska et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Ruthenium-based chemotherapeutics: are they ready for prime time?
- (2010) Emmanuel S. Antonarakis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Recent Insights on the Medicinal Chemistry of Metal-Based Compounds: Hints for the Successful Drug Design
- (2010) M. Z. Hernandes et al. CURRENT MEDICINAL CHEMISTRY
- Novel Metals and Metal Complexes as Platforms for Cancer Therapy
- (2010) Michael Frezza et al. CURRENT PHARMACEUTICAL DESIGN
- Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339
- (2010) Petra Heffeter et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Organometallic ruthenium-based antitumor compounds with novel modes of action
- (2010) Wee Han Ang et al. JOURNAL OF ORGANOMETALLIC CHEMISTRY
- Regarding ruthenium
- (2010) Simon Higgins Nature Chemistry
- Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study
- (2009) Frederike Lentz et al. ANTI-CANCER DRUGS
- Gold (III) porphyrin complexes induce apoptosis and cell cycle arrest and inhibit tumor growth in colon cancer
- (2009) Shuiping Tu et al. CANCER
- Multidrug resistance-associated proteins and implications in drug development
- (2009) Ya-He Liu et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- On the medicinal chemistry of gold complexes as anticancer drugs
- (2009) Ingo Ott COORDINATION CHEMISTRY REVIEWS
- Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
- (2009) Di Chen et al. CURRENT PHARMACEUTICAL DESIGN
- Recent developments in ruthenium anticancer drugs
- (2009) Aviva Levina et al. Metallomics
- Structural basis for the sequence-dependent effects of platinum–DNA adducts
- (2009) Srinivas Ramachandran et al. NUCLEIC ACIDS RESEARCH
- KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
- (2008) Christian G. Hartinger et al. CHEMISTRY & BIODIVERSITY
- Substrates and Inhibitors of Human Multidrug Resistance Associated Proteins and the Implications in Drug Development
- (2008) Shu-Feng Zhou et al. CURRENT MEDICINAL CHEMISTRY
- New trends for metal complexes with anticancer activity
- (2008) Pieter CA Bruijnincx et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Gold(I) complexes determine apoptosis with limited oxidative stress in Jurkat T cells
- (2008) Maria Pia Rigobello et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Synthesis and Reactivity of the Aquation Product of the Antitumor Complextrans-[RuIIICl4(indazole)2]−
- (2008) Berta Cebrián-Losantos et al. INORGANIC CHEMISTRY
- Antitumour metal compounds: more than theme and variations
- (2007) Michael A. Jakupec et al. DALTON TRANSACTIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now